EMILY MARU: Open Payments
NPI 1578189650 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,394 in 86 payments from 24 companies in 2025. Trend: 2023 $709 · 2024 $1,429 · 2025 $2,394
Food & beverage: $2,339Education: $55
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $474 |
| Sumitomo Pharma America, Inc. | 20 | $369 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $252 |
| PFIZER INC. | 9 | $220 |
| IMMUNITYBIO, INC. | 3 | $191 |
| UROGEN PHARMA, INC. | 5 | $109 |
| Novartis Pharmaceuticals Corporation | 3 | $91 |
| TOLMAR, INC. | 4 | $87 |
| ABBVIE INC. | 4 | $79 |
| Merck Sharp & Dohme LLC | 3 | $75 |
Products named: ERLEADA, Nubeqa, GEMTESA, XTANDI, ANKTIVA, ORGOVYX, PLUVICTO, PYLARIFY.
Industry payments across MD — which companies pay providers there.
